Skip to main
MMED

MMED Stock Forecast & Price Target

MMED Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 50%
Hold 10%
Sell 0%
Strong Sell 0%

Bulls say

Minimed Group is a strong player in the global diabetes management market, with a history of successful product launches and a solid financial position. Despite facing competition and regulatory risks, the company has a positive outlook due to its innovative products and plans for further growth and market share expansion. Its strong financial position provides a solid foundation for continued success in the growing diabetes market.

Bears say

Minimed Group is currently facing intense competition and pressure to offer economically attractive solutions, which could limit its pricing power and compress margins. As these technologies become more widely adopted, there is a risk that payers may limit reimbursement or negotiate for tighter discounts, which could adversely affect the company's financials. Additionally, MiniMed's reliance on a few key products for the majority of its revenue leaves it vulnerable to potential regulatory and reimbursement changes.

MMED has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 50% recommend Buy, 10% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of MiniMed Group Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About MiniMed Group Inc (MMED) Forecast

Analysts have given MMED a Buy based on their latest research and market trends.

According to 10 analysts, MMED has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

MiniMed Group Inc (MMED)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.